Daniel D. Rhoads, M.D. PhD

Section Head of Microbiology
Cleveland Clinic Foundation

Disclosure(s): Luminex: Advisor/Consultant; Talis Biomedical: Advisor/Consultant; Thermo Fisher: Advisor/Consultant

Poster(s):

• 142 - Evaluation of Meropenem-Vaborbactam Susceptibility and Underlying Resistance Mechanisms among Clinical KPC-producing Klebsiella pneumoniae
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1064 - Intra-Host SARS-CoV-2 Evolution Dynamics
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET